- Accueil >
- Publications >
- Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes
Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes
Auteurs
Lisa Golmard, Jean-Louis Golmard, Dominique Stoppa-Lyonnet